X4 Pharmaceuticals (XFOR) Misses Q3 EPS by 69c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.69). Revenue for the quarter came in at $1.76 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.69). Revenue for the quarter came in at $1.76 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.